Figure 3 | Scientific Reports

Figure 3

From: Direct chemotherapeutic dual drug delivery through intra-articular injection for synergistic enhancement of rheumatoid arthritis treatment

Figure 3

(a) TNF-α release amount in RAW 264.7 cells without and with Dex-M, Met-HA, or Met-HA/Dex-M at 1, 9 and 17 days of treatment (*p < 0.05, **p < 0.005). (b) Relative cell viability of RAW 264.7 cells at 1, 5, 9, 13 and 17 days of treatment (#p < 0.001). Dot line represents controls without injectable formulation at each time.

Back to article page